JO3254B1 - Dipeptidyl Peptidase inhibitors for Treating diabetes - Google Patents

Dipeptidyl Peptidase inhibitors for Treating diabetes

Info

Publication number
JO3254B1
JO3254B1 JOP/2006/0309A JOP20060309A JO3254B1 JO 3254 B1 JO3254 B1 JO 3254B1 JO P20060309 A JOP20060309 A JO P20060309A JO 3254 B1 JO3254 B1 JO 3254B1
Authority
JO
Jordan
Prior art keywords
treating diabetes
dipeptidyl peptidase
peptidase inhibitors
pharmaceutical compositions
well
Prior art date
Application number
JOP/2006/0309A
Other languages
Arabic (ar)
Inventor
Ronald J Christopher
Paul Covington
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Application granted granted Critical
Publication of JO3254B1 publication Critical patent/JO3254B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pharmaceutical compositions comprising 2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1- ylmethyl]-4-fluoro benzonitrile and pharmaceutical acceptable salts thereof are provided as well as kits and articles of manufacture comprising the Pharmaceutical compositions as well as methods of using the Pharmaceutical compositions.
JOP/2006/0309A 2005-09-14 2006-09-13 Dipeptidyl Peptidase inhibitors for Treating diabetes JO3254B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71756005P 2005-09-14 2005-09-14

Publications (1)

Publication Number Publication Date
JO3254B1 true JO3254B1 (en) 2018-09-16

Family

ID=50831057

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2006/0309A JO3254B1 (en) 2005-09-14 2006-09-13 Dipeptidyl Peptidase inhibitors for Treating diabetes

Country Status (3)

Country Link
AR (1) AR109064A2 (en)
JO (1) JO3254B1 (en)
UA (1) UA93689C2 (en)

Also Published As

Publication number Publication date
UA93689C2 (en) 2011-03-10
AR109064A2 (en) 2018-10-24

Similar Documents

Publication Publication Date Title
NO20081592L (en) Dipeptidyl peptidase inhibitors for the treatment of diabetes
MX2009002772A (en) Administration of dipeptidyl peptidase inhibitors.
MY159522A (en) Administration of dipeptidyl peptidase inhibitors
MY149157A (en) Weekly administration of dipeptidyl peptidase inhibitors
WO2009108383A3 (en) Substituted xanthine derivatives
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
MX2009008253A (en) Kinase inhibitors.
TW200606162A (en) Pyrazolopyridine derivatives
MX2009006690A (en) Aminopyrimidines useful as inhibitors of protein kinases.
MX2009009591A (en) Aminopyrimidines useful as inhibitors of protein kinases.
MX2009006345A (en) Compounds useful as protein kinase inhibitors.
IN2012DN01641A (en)
WO2007120333A3 (en) Tetracyclic kinase inhibitors
MX2008011633A (en) Aminoquinolones as gsk-3 inhibitors.
TW200745088A (en) Benzimidazoles useful as inhibitors of protein kinases
MX2010006206A (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases.
MX2007001953A (en) Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer.
IN2012DN01642A (en)
MX2008015775A (en) Compounds and compositions for treatment of cancer.
MX2009005231A (en) Compounds useful as protein kinase inhibitors.
TW200738723A (en) 1-(1-(2-Ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl)piperidine-4-carboxylic acid and salts thereof
JO3254B1 (en) Dipeptidyl Peptidase inhibitors for Treating diabetes
JO3721B1 (en) Administration of Dipeptidyl Peptidase inhibitors
UA95260C2 (en) 4-(3-aminopyrazole) pyrimidine derivative and use thereof in the treatment of cancer
UA99112C2 (en) Use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydr0-2h-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile